CVS Health Corporation $CVS Shares Bought by BNP Paribas

BNP Paribas boosted its holdings in shares of CVS Health Corporation (NYSE:CVS – Free Report) by 27.8% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 63,847 shares of the pharmacy operator’s stock after acquiring an additional 13,876 shares during the quarter. BNP Paribas’ holdings in CVS Health were worth $6,026,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CVS. Kilter Group LLC acquired a new position in shares of CVS Health during the 2nd quarter worth $27,000. J.Safra Asset Management Corp acquired a new stake in shares of CVS Health in the 2nd quarter valued at $30,000. Beaird Harris Wealth Management LLC boosted its holdings in CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 195 shares in the last quarter. Timbuktu Capital Management LLC bought a new stake in CVS Health in the second quarter worth $31,000. Finally, Dunhill Financial LLC acquired a new position in CVS Health during the second quarter worth $32,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Trading Up 1.0%

NYSE:CVS opened at $80.83 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.66 and a debt-to-equity ratio of 0.71. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The firm has a market capitalization of $103.42 billion, a price-to-earnings ratio of 9.41, a PEG ratio of 0.70 and a beta of 0.58. The business’s 50-day moving average price is $88.42 and its two-hundred day moving average price is $89.29.

CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, November 4th. The pharmacy operator reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.44. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The business had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. During the same period last year, the business posted $1.60 earnings per share. The firm’s quarterly revenue was up 5.4% on a year-over-year basis. On average, equities analysts expect that CVS Health Corporation will post 8.26 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 2nd. Stockholders of record on Thursday, October 22nd were paid a $0.6650 dividend. The ex-dividend date was Thursday, October 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. CVS Health’s dividend payout ratio (DPR) is presently 30.97%.

Insider Activity at CVS Health

In related news, EVP Prem Shah acquired 23,855 shares of the company’s stock in a transaction that occurred on Friday, November 6th. The stock was acquired at an average price of $83.89 per share, with a total value of $2,001,195.95. Following the purchase, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.85% of the company’s stock.

Top CVS Health Stories

Here are a few of the latest stories about CVS:

  • Positive Sentiment: CVS ranked ninth on a recent “affordable blue chip stocks” list, which may reinforce its value-stock appeal, but the ranking itself is not a fundamental change to the business. Article: Why CVS Health cracked the Best Affordable Blue Chip Stocks list
  • Neutral Sentiment: Aetna launched a five-year maternal and infant-care initiative, targeting access to essential care for 90% of members by 2032. It may support member engagement over time, but the announcement offers no clear near-term earnings impact. Article: Aetna For You & Baby initiative
  • Negative Sentiment: Renewed momentum for “Medicare for All” was cited as a factor weighing on health-insurer stocks. The prospect of major changes to private insurance could create sector-wide uncertainty for CVS and its Aetna business. Article: Medicare For All momentum sinks health insurer stocks

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Barclays lowered their price target on CVS Health from $108.00 to $107.00 and set an “overweight” rating on the stock in a report on Thursday, November 5th. BMO Capital Markets set a $112.00 price objective on shares of CVS Health in a research note on Wednesday, September 9th. Wells Fargo & Company decreased their price objective on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating for the company in a report on Thursday, November 12th. Argus lifted their target price on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. Finally, UBS Group dropped their target price on shares of CVS Health from $118.00 to $107.00 and set a “buy” rating on the stock in a report on Thursday, November 5th. Twenty-three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $107.33.

Check Out Our Latest Stock Analysis on CVS Health

CVS Health Profile

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Read More

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.